Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012

AIDS

Volumn 29, Issue 1, 2015, Pages 117-123

  Rough, Kathryn ^a   Tassiopoulos, Katherine ^a   Kacanek, Deborah ^b   Griner, Raymond ^c   Yogev, Ram ^d   Rich, Kenneth C ^e   Seage, George R ^a   Shearer, William ^f   Paul, Mary ^f   Cooper, Norma ^f   Harris, Lynette ^f   Purswani, Murli ^g   Stuard, Emma ^g   Cintron, Anna ^g   Puga, Ana ^h   Cooley, Dia ^h   Patton, Doyle ^h   Leon, Deyana ^h   Sanders, Margaret Ann ^d   Malee, Kathleen ^d   Hunter, Scott ^d   Borkowsky, William ⁱ   Deygoo, Sandra ⁱ   Rozelman, Helen ⁱ   Knapp, Katherine ^j   Allison, Kim ^j   Wilkins, Megan ^j   Acevedo Flores, Midnela ^k   Angeli Nieves, Lourdes ^k   Olivera, Vivian ^k   Mendez, Hermann ^l   Dennie, Ava ^l   Bewley, Susan ^l   Van Dyke, Russell ^m   Craig, Karen ^m   Sirois, Patricia ^m   Crain, Marilyn ⁿ   Beatty, Newana ⁿ   Marullo, Dan ⁿ   Spector, Stephen ^o   Manning, Jean ^o   Nichols, Sharon ^o   McFarland, Elizabeth ^p   Barr, Emily ^p   McEvoy, Robin ^p   Rathore, Mobeen ^q   Stowers, Kristi ^q   Usitalo, Ann ^q   Richardson, Lourdes ^e   Turpin, Delmyra ^e   Smith, Renee ^e   Dieudonne, Arry ^r   Bettica, Linda ^r   Adubato, Susan ^r   Scott, Gwendolyn ^s   Florez, Claudia ^s   Willen, Elizabeth ^s   Frederick, Toinette ^t   Davtyan, Mariam ^t   Mejia, Maribel ^t   Rodriguez, Zoe ^u   Heyer, Ibet ^u   Trifilio, Nydia Scalley ^u   more..

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d CHILDREN'S MEMORIAL HOSPITAL   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g BRONX LEBANON HOSPITAL CENTER   (United States)

^h Children's Diagnostic and Treatment Center   (United States)

ⁱ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^k San Juan Scientific   (United States)

^l SUNY DOWNSTATE MEDICAL CENTER   (United States)

^m TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

ⁿ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^q UNIVERSITY OF FLORIDA   (United States)

^r UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^s UNIVERSITY OF MIAMI   (United States)

^t UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^u UNIVERSITY OF PUERTO RICO   (Puerto Rico)

more..

Author keywords

Epidemiology; HIV; Pregnancy; Substance abuse

Indexed keywords

ALCOHOL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CANNABIS; COCAINE; DIAMORPHINE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; EPIDEMIC; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SUBSTANCE USE; TOBACCO; UNITED STATES; URINALYSIS; HIV INFECTIONS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDY; SUBSTANCE-RELATED DISORDERS; VERTICAL TRANSMISSION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 84928042834     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000503     Document Type: Article

References (50)

1. Taylor AW, Little KM, Zhang X, Borkowf CB, Whitmore SK, Weidle PJ, et al. Estimated perinatal antiretroviral exposures, cases prevented and infected infants in the era of antiretroviral prophylaxis in the United States. 19th Conference on Retroviruses and Opportunistic Infections. Seattle, WA; March 5-8, 2012
2. Whitmore SK, Zhang X, Taylor AW, Blair JM. Estimated number of infants born to HIV-infected women in the United States and five dependent areas, 2006. J Acquir Immune Defic Syndr 2011; 57:218-222
3. Nair P, Alger L, Hines S, Seiden S, Hebel R, Johnson JP. Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J Acquir Immune Defic Syndr 1993; 6:298-302
4. Rodriguez EM, Mendez H, Rich K, Sheon A, Fox H, Green K, et al. Maternal drug use in perinatal HIV studies. The Women and Infants Transmission Study. Ann N Y Acad Sci 1993; 693:245-248
5. Landesman SH, Kalish LA, Burns DN, Minkoff H, Fox HE, Zorrilla C, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 1996; 334:1617-1623
6. Purohit V, Rapaka RS, Schnur P, Shurtleff D. Potential impact of drugs of abuse on mother-to-child transmission (MTCT) of HIV in the era of highly active antiretroviral therapy (HAART). Life Sci 2011; 88:909-916
7. Rodriguez EM, Mofenson LM, Chang BH, Rich KC, Fowler MG, Smeriglio V, et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS 1996; 10:273-282
8. Whitmore SK, Taylor AW, Espinoza L, Shouse RL, Lampe MA, Nesheim S. Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico. Pediatrics 2012; 129:e74-e81
9. Bateman DA, Ng SK, Hansen CA, Heagarty MC. The effects of intrauterine cocaine exposure in newborns. Am J Public Health 1993; 83:190-193
10. Day NL, Richardson GA, Geva D, Robles N. Alcohol, marijuana, and tobacco: effects of prenatal exposure on offspring growth and morphology at age six. Alcohol Clin Exp Res 1994; 18:786-794
11. Day NL, Richardson GA, Goldschmidt L, Robles N, Taylor PM, Stoffer DS, et al. Effect of prenatal marijuana exposure on the cognitive development of offspring at age three. Neurotoxicol Teratol 1994; 16:169-175
12. Goldschmidt L, Richardson GA, Willford J, Day NL. Prenatal marijuana exposure and intelligence test performance at age 6. J Am Acad Child Adolesc Psychiatry 2008; 47:254-263
13. Levine TP, Liu J, Das A, Lester B, Lagasse L, Shankaran S, et al. Effects of prenatal cocaine exposure on special education in school-aged children. Pediatrics 2008; 122:e83-e91
14. Lightwood JM, Phibbs CS, Glantz SA. Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics 1999; 104:1312-1320
15. Richardson GA, Goldschmidt L, Larkby C. Effects of prenatal cocaine exposure on growth: a longitudinal analysis. Pediatrics 2007; 120:e1017-e1027
16. Riley EP, McGee CL. Fetal alcohol spectrum disorders: an overview with emphasis on changes in brain and behavior. Exp Biol Med 2005; 230:357-365.
17. Sexton M, Fox NL, Hebel JR. Prenatal exposure to tobacco: II. Effects on cognitive functioning at age three. Int J Epidemiol 1990; 19:72-77
18. Stroud LR, Paster RL, Goodwin MS, Shenassa E, Buka S, Niaura R, et al. Maternal smoking during pregnancy and neonatal behavior: a large-scale community study. Pediatrics 2009; 123:e842-e848
19. Zuckerman B, Frank DA, Hingson R, Amaro H, Levenson SM, Kayne H, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989; 320:762-768
20. Katz IT, Shapiro R, Li D, Govindarajulu U, Thompson B, Watts DH, et al. Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the Women and Infants Transmission Study. J Acquir Immune Defic Syndr 2010; 54:27-34
21. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, January 1991, pp. 9-10
22. Centers for Disease Control and Prevention. HIV Surveillance Report, 2013, 23:17-20
23. Sheon AR, Fox HE, Rich KC, Stratton P, Diaz C, Tuomala R, et al. The Women and Infants Transmission Study (WITS) of maternal-infant HIV transmission: study design, methods, and baseline data. J Women's Health 1996; 5:69-78
24. Williams PL, Seage GR 3rd, Van Dyke RB, Siberry GK, Griner R, Tassiopoulos K, et al. A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers. Am J Epidemiol 2012; 175:950-961
25. Tassiopoulos K, Read JS, Brogly S, Rich K, Lester B, Spector SA, et al. Substance use in HIV-infected women during pregnancy: self-report versus meconium analysis. AIDS Behav 2010; 14:1269-1278
26. Substance Abuse and Mental Health Services Administration. Results from the 1994 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 1995
27. Substance Abuse and Mental Health Services Administration. Results from the 1995 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 1996
28. Substance Abuse and Mental Health Services Administration. Results from the 1996 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 1997
29. Substance Abuse and Mental Health Services Administration. Results from the 1997 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 1998
30. Substance Abuse and Mental Health Services Administration. Results from the 1998 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 1999
31. Substance Abuse and Mental Health Services Administration. Results from the 1999 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2000
32. Substance Abuse and Mental Health Services Administration. Results from the 2000 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2001
33. Substance Abuse and Mental Health Services Administration. Results from the 2001 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2002
34. Substance Abuse and Mental Health Services Administration. Results from the 2002 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2003
35. Substance Abuse and Mental Health Services Administration. Results from the 2003 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2004
36. Substance Abuse and Mental Health Services Administration. Results from the 2004 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2005
37. Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2006
38. Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2007
39. Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2008
40. Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2009
41. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2010
42. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2011
43. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2012
44. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies; 2013
45. Sohler NL, Wong MD, Cunningham WE, Cabral H, Drainoni ML, Cunningham CO. Type and pattern of illicit drug use and access to healthcare services for HIV-infected people. AIDS Patient Care STDS 2007; 21 (Suppl 1):S68-S76
46. Celentano DD, Vlahov D, Cohn S, Shadle VM, Obasanjo O, Moore RD. Self-reported antiretroviral therapy in injection drug users. JAMA 1998; 280:544-546
47. Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998; 280:547-549
48. Halstead AC, Godolphin W, Lockitch G, Segal S. Timing of specimen collection is crucial in urine screening of drug dependent mothers and newborns. Clin Biochem 1988; 21:59-61
49. Ostrea EM, Brady M, Gause S, Raymundo AL, Stevens M. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics 1992; 89:107-113
50. Ostrea EM Jr, Knapp DK, Tannenbaum L, Ostrea AR, Romero A, Salari V, et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001; 138:344-348.